- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05871060
Effect of a Novel Protein Supplement on Appetite in Older Adults
November 23, 2023 updated by: Katy Horner, University College Dublin
An acute randomized crossover trial comparing the effects of the whey hydrolysate, whey protein concentrate and placebo (still flavored water) on appetite and energy intake in older adults.
Both low-dose whey-derived treatment and placebo will be administered 30 minutes prior to breakfast and lunch meals.
Moreover, ghrelin secretion and activity will be monitored throughout the morning until the lunch time.
Appetite will be assessed through visual analogue scale questionnaires.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Leinster
-
Dublin, Leinster, Ireland, D04 V1W8
- University College Dublin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Community-dwelling,
- Age 60+ years
- Poor appetite (Simplified Nutritional Appetite Questionnaire (SNAQ) score </=14, answer a, b or c to Q.1 on SNAQ or answer b, c, or d to CES-D question regarding poor appetite in the past week)
- BMI 20-25kg/m2
Exclusion Criteria:
- Current medical condition or medication known to impact appetite or energy intake
- Other medical condition that would impact study participation and outcomes, as judged by the study investigator.
- Heavy smoker (>10/day)
- Inability to come to study centre
- Currently participating in another intervention study
- Lacking informed consent
- Allergic to or unwilling to consume any of the study test foods
- Loss of taste or smell associated with COVID-19
- Unable to walk across a room
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: whey concentrate supplement
2,2 grams of whey concentrate dissolved in 100 mL of water
|
Whey protein concentrate consumed 30 minutes prior to breakfast and lunch meals
|
|
Experimental: whey hydrolysate supplement
2,2 grams of whey hydrolysate dissolved in 100 mL of water
|
Whey hydrolysate consumed 30 minutes prior to breakfast and lunch meals
|
|
Placebo Comparator: still flavoured water
100 mL of vanilla-flavoured water
|
Flavoured water consumed 30 minutes prior to breakfast and lunch meals
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pre-meal and changes in Composite Appetite Score
Time Frame: 8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes after ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and lunch test meal. And immediately after each test meal.
|
Validated 100 millimetre Visual Analogue Scales (VAS) will be used to assess appetite, at fourteen (14) set time points throughout the experimental visit.
This VAS has anchors located at each end of the scale.
On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
Composite Appetite Score is derived from VAS ratings of hunger, fullness, desire to eat and prospective food consumption.
|
8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes after ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and lunch test meal. And immediately after each test meal.
|
|
Energy intake (EI) (kilocalories)
Time Frame: 24 hours from breakfast, lunch and dinner meals, as well as from evening and night from provided snackbox.
|
24-hour energy intake measurement.
Participants will be served a standardised fixed breakfast and ad libitum lunch and dinner meals in the laboratory and provided with an evening snack box.
24 hour EI (kilocalories) will be measured objectively, by weighing foods before and after consumption and calculating energy intake based on their nutritional data.
Total accumulated energy intake includes standard breakfast meal, ad libitum lunch meal, ad libitum dinner meal and bag with known foods for the evening time.
|
24 hours from breakfast, lunch and dinner meals, as well as from evening and night from provided snackbox.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Palatability - Pleasantness
Time Frame: Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
100 millimetre Visual Analogue Scales (VAS) will be used after each test meal: breakfast, lunch and dinner.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
|
Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
|
Palatability - Filling
Time Frame: Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
100 millimetre Visual Analogue Scales (VAS) will be used after each test meal: breakfast, lunch and dinner.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
|
Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
|
Palatability - Satisfaction
Time Frame: Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
100 millimetre Visual Analogue Scales (VAS) will be used after each test meal: breakfast, lunch and dinner.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
|
Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
|
Palatability - Taste
Time Frame: Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
100 millimetre Visual Analogue Scales (VAS) will be used after each test meal: breakfast, lunch and dinner.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
|
Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
|
Palatability - Sweet
Time Frame: Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
100 millimetre Visual Analogue Scales (VAS) will be used after each test meal: breakfast, lunch and dinner.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
|
Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
|
Palatability - Savoury
Time Frame: Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
100 millimetre Visual Analogue Scales (VAS) will be used after each test meal: breakfast, lunch and dinner.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
|
Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
|
Pre-meal and changes in glucose
Time Frame: 4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
Blood samples will be collected by a trained phlebotomist via cannula.
|
4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
|
Pre-meal and changes in insulin
Time Frame: 4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
Blood samples will be collected by a trained phlebotomist via cannula.
|
4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
|
Pre-meal and changes in growth hormone
Time Frame: 4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
Blood samples will be collected by a trained phlebotomist via cannula.
|
4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
|
Pre-meal and changes in cortisol
Time Frame: 4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
Blood samples will be collected by a trained phlebotomist via cannula.
|
4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
|
Pre-meal and changes in GLP-1
Time Frame: 4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
Blood samples will be collected by a trained phlebotomist via cannula.
|
4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
|
Pre-meal and changes in PYY
Time Frame: 4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
Blood samples will be collected by a trained phlebotomist via cannula.
|
4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
|
Pre-meal and changes in Total Ghrelin
Time Frame: 4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
Blood samples will be collected by a trained phlebotomist via cannula.
|
4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
|
Pre-meal and changes in Acylated Ghrelin
Time Frame: 4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
Blood samples will be collected by a trained phlebotomist via cannula.
|
4 hours, from fasting state (morning) to immediately prior to lunch meal (afternoon): fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement
|
|
Pre-meal and changes in Hunger
Time Frame: 8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and test meal.
|
Validated 100 mm Visual Analogue Scales (VAS) will be used to estimate changes in appetite, assessed at fourteen (14) set time points throughout the experimental visit.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the extreme positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
Composite Appetite Score derived from aspects such as hunger, fullness, desire to eat and prospective food consumption will be calculated.
Fasting, mean and AUC values will be calculated.
|
8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and test meal.
|
|
Pre-meal and changes in Fullness
Time Frame: 8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and test meal.
|
Validated 100 mm Visual Analogue Scales (VAS) will be used to estimate changes in appetite, assessed at fourteen (14) set time points throughout the experimental visit.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the extreme positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
Composite Appetite Score derived from aspects such as hunger, fullness, desire to eat and prospective food consumption will be calculated.
Fasting, mean and AUC values will be calculated.
|
8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and test meal.
|
|
Pre-meal and changes in Desire to Eat
Time Frame: 8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and test meal.
|
Validated 100 mm Visual Analogue Scales (VAS) will be used to estimate changes in appetite, assessed at fourteen (14) set time points throughout the experimental visit.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the extreme positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
Composite Appetite Score derived from aspects such as hunger, fullness, desire to eat and prospective food consumption will be calculated.
Fasting, mean and AUC values will be calculated.
|
8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and test meal.
|
|
Pre-meal and changes in Prospective Food Consumption
Time Frame: 8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and test meal.
|
Validated 100 mm Visual Analogue Scales (VAS) will be used to estimate changes in appetite, assessed at fourteen (14) set time points throughout the experimental visit.
This VAS has anchors located at each end of the scale.
On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the extreme positive response.
Participants mark along the line where it most represents their subjective perception between both ends.
Composite Appetite Score derived from aspects such as hunger, fullness, desire to eat and prospective food consumption will be calculated.
Fasting, mean and AUC values will be calculated.
|
8.5 hours: fasting, before breakfast, at 30, 60, 120, 180 and 210 minutes following ingestion of supplement and a standard meal; at 30, 60, 120 and 180 minutes following ingestion of supplement and test meal.
|
|
Liking of test meals
Time Frame: Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
9-point likert scale from 0 dislike extremely to 9 like extremely
|
Mean of ratings taken immediately following the three test meals (single measure) - breakfast, lunch and dinner
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 25, 2023
Primary Completion (Actual)
September 15, 2023
Study Completion (Actual)
October 30, 2023
Study Registration Dates
First Submitted
March 31, 2023
First Submitted That Met QC Criteria
May 13, 2023
First Posted (Actual)
May 23, 2023
Study Record Updates
Last Update Posted (Actual)
November 27, 2023
Last Update Submitted That Met QC Criteria
November 23, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LS-22-64-Horner
- TC201800025 (Other Grant/Funding Number: Food for Health Ireland)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Arizona State UniversityActive, not recruiting
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
Clinical Trials on Whey Protein Concentrate
-
University of the Incarnate WordCompleted
-
Auburn UniversityCompletedSkeletal Muscle
-
University of LimerickMarigot Ltd.; Enterprise IrelandCompletedBioavailability of Amino Acids Following Oral Ingestion of Plant-Based Proteins in Young, Healthy MenIreland
-
University of LimerickCompleted
-
Loughborough UniversityVolac International LimitedRecruitingAgeing Well | Neuromuscular FunctionUnited Kingdom
-
Wageningen University and ResearchCompleted
-
All India Institute of Medical Sciences, New DelhiCompleted
-
Norwegian School of Sport SciencesArkansas Children's Hospital Research Institute; TineCompletedHealthy Participants
-
Oxford Brookes UniversityRoquette FrèresCompletedHealthyUnited Kingdom
-
Wageningen University and ResearchCompleted